Copyright
©The Author(s) 2016. Published by Baishideng Publishing Group Inc. All rights reserved.
World J Meta-Anal. Oct 26, 2016; 4(5): 105-117
Published online Oct 26, 2016. doi: 10.13105/wjma.v4.i5.105
Published online Oct 26, 2016. doi: 10.13105/wjma.v4.i5.105
Isolated hepatic perfusion for unresectable hepatic malignancies: A systematic review and meta-analysis
Tian Meng, Meng-Hua Dai, Department of General Surgery, Peking Union Medical College Hospital, Beijing 100730, China
Guan-Qiao Li, Peking Union Medical College, Beijing 100730, China
Guan-Qiao Li, Medical School, Tsinghua University, Beijing 100085, China
Author contributions: Meng T and Dai MH designed the research; Meng T and Li GQ performed the research; Meng T analyzed the data; Meng T and Li GQ wrote the paper; Dai MH reviewed the manuscript.
Conflict-of-interest statement: All the authors declare that they have no competing interests.
Data sharing statement: No additional data are available.
Open-Access: This article is an open-access article which was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/
Correspondence to: Tian Meng, MD, Department of General Surgery, Peking Union Medical College Hospital, No.1 Shuaifuyuan Wangfujing, Dongcheng District, Beijing 100730, China. 42556973@qq.com
Telephone: +86-10-81568211
Received: April 3, 2016
Peer-review started: April 7, 2016
First decision: June 12, 2016
Revised: June 24, 2016
Accepted: August 15, 2016
Article in press: August 16, 2016
Published online: October 26, 2016
Processing time: 201 Days and 1 Hours
Peer-review started: April 7, 2016
First decision: June 12, 2016
Revised: June 24, 2016
Accepted: August 15, 2016
Article in press: August 16, 2016
Published online: October 26, 2016
Processing time: 201 Days and 1 Hours
Core Tip
Core tip: The treatment of unresectable liver malignancies is an important and difficult clinical problem. Many studies suggested that isolated hepatic perfusion to be efficacious and safe in the management of unresectable liver malignancies. However, there has not yet been a systematic analysis to evaluate this method. Therefore we reviewed all the literature we could get and conducted a systemic review. In the present systemic review we demonstrated all details and results of this technique in every aspect and intensively investigated these data, so that it will help readers to understand this technique in a quick, comprehensive and objective way.